Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1995 Jun;39(6):680–683. doi: 10.1111/j.1365-2125.1995.tb05729.x

Prolonged half-life of verapamil in a case of overdose: implications for therapy.

C D Buckley 1, J K Aronson 1
PMCID: PMC1365082  PMID: 7654488

Abstract

After an overdose of verapamil (2.4 g) in a 59-year-old man the apparent half-life of verapamil was prolonged (15 h). The most likely mechanism is rate-limiting absorption, although changes in clearance and volume of distribution may contribute. As the elimination half-life of verapamil is increased in overdose, therapy may have to be continued for longer than expected. Moreover since the half-life of absorption of verapamil in overdose may be prolonged, activated charcoal should be given in repeated doses, even if an ordinary-release formulation has been taken.

Full text

PDF
683

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Buckley N., Dawson A. H., Howarth D., Whyte I. M. Slow-release verapamil poisoning. Use of polyethylene glycol whole-bowel lavage and high-dose calcium. Med J Aust. 1993 Feb 1;158(3):202–204. [PubMed] [Google Scholar]
  2. Crump B. J., Holt D. W., Vale J. A. Lack of response to intravenous calcium in severe verapamil poisoning. Lancet. 1982 Oct 23;2(8304):939–940. doi: 10.1016/s0140-6736(82)90912-6. [DOI] [PubMed] [Google Scholar]
  3. Doyon S., Roberts J. R. The use of glucagon in a case of calcium channel blocker overdose. Ann Emerg Med. 1993 Jul;22(7):1229–1233. doi: 10.1016/s0196-0644(05)80997-7. [DOI] [PubMed] [Google Scholar]
  4. Freedman S. B., Richmond D. R., Ashley J. J., Kelly D. T. Verapamil kinetics in normal subjects and patients with coronary artery spasm. Clin Pharmacol Ther. 1981 Nov;30(5):644–652. doi: 10.1038/clpt.1981.216. [DOI] [PubMed] [Google Scholar]
  5. Hamann S. R., Blouin R. A., McAllister R. G., Jr Clinical pharmacokinetics of verapamil. Clin Pharmacokinet. 1984 Jan-Feb;9(1):26–41. doi: 10.2165/00003088-198409010-00002. [DOI] [PubMed] [Google Scholar]
  6. Hendren W. G., Schieber R. S., Garrettson L. K. Extracorporeal bypass for the treatment of verapamil poisoning. Ann Emerg Med. 1989 Sep;18(9):984–987. doi: 10.1016/s0196-0644(89)80465-2. [DOI] [PubMed] [Google Scholar]
  7. Hofer C. A., Smith J. K., Tenholder M. F. Verapamil intoxication: a literature review of overdoses and discussion of therapeutic options. Am J Med. 1993 Oct;95(4):431–438. doi: 10.1016/0002-9343(93)90314-f. [DOI] [PubMed] [Google Scholar]
  8. Horowitz B. Z., Rhee K. J. Massive verapamil ingestion: a report of two cases and a review of the literature. Am J Emerg Med. 1989 Nov;7(6):624–631. doi: 10.1016/0735-6757(89)90287-8. [DOI] [PubMed] [Google Scholar]
  9. Kates R. E., Keefe D. L., Schwartz J., Harapat S., Kirsten E. B., Harrison D. C. Verapamil disposition kinetics in chronic atrial fibrillation. Clin Pharmacol Ther. 1981 Jul;30(1):44–51. doi: 10.1038/clpt.1981.125. [DOI] [PubMed] [Google Scholar]
  10. Kenny J. Treating overdose with calcium channel blockers. BMJ. 1994 Apr 16;308(6935):992–993. doi: 10.1136/bmj.308.6935.992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Krick S. E., Gums J. G., Grauer K., Cooper G. R. Severe verapamil (sustained-release) overdose. DICP. 1990 Jul-Aug;24(7-8):705–706. doi: 10.1177/106002809002400711. [DOI] [PubMed] [Google Scholar]
  12. Minella R. A., Schulman D. S. Fatal verapamil toxicity and hypokalemia. Am Heart J. 1991 Jun;121(6 Pt 1):1810–1812. doi: 10.1016/0002-8703(91)90033-e. [DOI] [PubMed] [Google Scholar]
  13. Sauder P., Kopferschmitt J., Dahlet M., Tritsch L., Flesch F., Siard P., Mantz J. M., Jaeger A. Les intoxications aiguës par le vérapamil. A propos de 6 cas. Revue de la littérature. J Toxicol Clin Exp. 1990 Jul-Aug;10(4):261–270. [PubMed] [Google Scholar]
  14. Shand D. G., Hammill S. C., Aanonsen L., Pritchett E. L. Reduced verapamil clearance during long-term oral administration. Clin Pharmacol Ther. 1981 Nov;30(5):701–706. doi: 10.1038/clpt.1981.223. [DOI] [PubMed] [Google Scholar]
  15. Somogyi A., Albrecht M., Kliems G., Schäfer K., Eichelbaum M. Pharmacokinetics, bioavailability and ECG response of verapamil in patients with liver cirrhosis. Br J Clin Pharmacol. 1981 Jul;12(1):51–60. doi: 10.1111/j.1365-2125.1981.tb01854.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES